Literature DB >> 10618068

Relationship of incremental specimen volumes and enhanced detection of human immunodeficiency virus type 1 RNA with nucleic acid amplification technology.

D J Witt1, M Kemper, A Stead, C C Ginocchio, A M Caliendo.   

Abstract

The relationship between specimen input volume and the frequency of reported human immunodeficiency virus type 1 (HIV-1) RNA copy numbers by nucleic acid amplification technology (the NASBA HIV-1 RNA QT system) was investigated. Results obtained with both clinical specimens and dilution panels indicated that both the absolute number of reported results and the reported HIV-1 RNA copy number were directly proportional to the specimen input volumes evaluated (0.1, 0.5, and 1.0 ml). Conversion of the reported HIV-1 RNA copy numbers to a constant 1.0-ml volume indicated that the numerical relationship among the specimen input volumes and the HIV-1 RNA copy numbers was multiplicative. The HIV-1 RNA copy numbers reported for the 0.5-ml input volume were approximately 5-fold increased over those reported for the 0.1-ml input volume, and those reported for the 1.0-ml input volume were 10-fold increased over those reported for the 0.1-ml input volume. For the specimen input volumes investigated, a common linear range of 264 to 5,400,000 HIV-1 RNA copies was observed. The use of increased specimen input volumes did not result in a loss of assay specificity, as the results reported for specimens from 50 seronegative blood donors were negative at all three specimen input volumes. In conclusion, an increase in the input volume of specimens analyzed by nucleic acid amplification technology can be useful for the enhanced detection of HIV-1 RNA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618068      PMCID: PMC86025          DOI: 10.1128/JCM.38.1.85-89.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Comparison of levels of human immunodeficiency virus type 1 RNA in plasma as measured by the NucliSens nucleic acid sequence-based amplification and Quantiplex branched-DNA assays.

Authors:  C C Ginocchio; S Tetali; D Washburn; F Zhang; M H Kaplan
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

2.  HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy.

Authors:  V Natarajan; M Bosche; J A Metcalf; D J Ward; H C Lane; J A Kovacs
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

3.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

4.  A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity.

Authors:  J Mulder; R Resnick; B Saget; S Scheibel; S Herman; H Payne; R Harrigan; S Kwok
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

5.  Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories.

Authors:  B Yen-Lieberman; D Brambilla; B Jackson; J Bremer; R Coombs; M Cronin; S Herman; D Katzenstein; S Leung; H J Lin; P Palumbo; S Rasheed; J Todd; M Vahey; P Reichelderfer
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

6.  A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes.

Authors:  B van Gemen; R van Beuningen; A Nabbe; D van Strijp; S Jurriaans; P Lens; T Kievits
Journal:  J Virol Methods       Date:  1994-09       Impact factor: 2.014

7.  Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma.

Authors:  C C Ginocchio; X P Wang; M H Kaplan; G Mulligan; D Witt; J W Romano; M Cronin; R Carroll
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

8.  Evaluation of the ultrasensitive Roche Amplicor HIV-1 monitor assay for quantitation of human immunodeficiency virus type 1 RNA.

Authors:  M Erali; D R Hillyard
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction.

Authors:  M A Winters; L B Tan; D A Katzenstein; T C Merigan
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

  9 in total
  5 in total

1.  Stochastic processes defining sensitivity and variability of internally calibrated quantitative NASBA-based viral load assays.

Authors:  Jos J A M Weusten; Pieter A W M Wouters; Martien C A van Zuijlen; Paul A van de Wiel
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

2.  Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women.

Authors:  Marek J Nowicki; Tomasz Laskus; Georgia Nikolopoulou; Marek Radkowski; Jeffrey Wilkinson; Wenbo B Du; Jorge Rakela; Andrea Kovacs
Journal:  J Infect Dis       Date:  2005-09-29       Impact factor: 5.226

3.  Longitudinal variability of human immunodeficiency virus type 1 RNA viral load measurements by nucleic acid sequence-based amplification and NucliSens assays in a large multicenter study.

Authors:  M J Nowicki; L Benning; J W Bremer; W A Meyer; C Hanson; D Brambilla; S Silver; A Kovacs
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma.

Authors:  D G Murphy; L Côté; M Fauvel; P René; J Vincelette
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

5.  Multicenter evaluation of the performance characteristics of the NucliSens HIV-1 QT assay used for quantitation of human immunodeficiency virus type 1 RNA.

Authors:  Christine C Ginocchio; Marti Kemper; Kathleen A Stellrecht; Donald J Witt
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.